Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep:191:110054.
doi: 10.1016/j.diabres.2022.110054. Epub 2022 Aug 28.

Does diabetes risk after SARS-CoV-2 infection depend on the viral variant?

Rohita Rangu  1 , Pandora L Wander  2 , Sakeneh Zraika  3
Affiliations

Does diabetes risk after SARS-CoV-2 infection depend on the viral variant?

Rohita Rangu et al. Diabetes Res Clin Pract. 2022 Sep.

Abstract

SARS-CoV-2 infection is associated with an elevated risk of new-onset diabetes. With infections forecast to rise in the coming months, this may exacerbate an existing public health crisis by increasing rates of diabetes worldwide. Much remains to be learned about a causal link between SARS-CoV-2 and incident diabetes. This is complicated by the rapid evolution of new SARS-CoV-2 variants that may have differential effects on development of diabetes. It is possible that some variants confer an increased risk, while others carry little to no risk. Distinguishing between these possibilities could be key in preventing or screening for new-onset diabetes, and could inform care of at-risk individuals with recent SARS-CoV-2 infection.

Keywords: COVID-19; Diabetes; Islets; SARS-CoV-2; Variant.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259–264. doi: 10.1038/s41586-021-03553-9. - DOI - PubMed
    1. Rewers M., Bonifacio E., Ewald D., Geno Rasmussen C., Jia X., Pyle L., et al. SARS-CoV-2 infections and presymptomatic type 1 diabetes autoimmunity in children and adolescents from Colorado, USA, and Bavaria, Germany. JAMA. 2022 doi: 10.1001/jama.2022.14092. - DOI - PMC - PubMed
    1. Ata A., Jalilova A., Kırkgöz T., Işıklar H., Demir G., Altınok Y.A., et al. Does COVID-19 predispose patients to type 1 diabetes mellitus? Clin Pediatr Endocrinol. 2021 doi: 10.1297/cpe.2021-0050. advpub. - DOI - PMC - PubMed
    1. Richter A.G., Shields A.M., Karim A., Birch D., Faustini S.E., Steadman L., et al. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection. Clin Exp Immunol. 2021;205:99–105. doi: 10.1111/cei.13623. - DOI - PMC - PubMed
    1. Ben Nasr M., D’Addio F., Montefusco L., Usuelli V., Loretelli C., Rossi A., et al. Indirect and direct effects of SARS-CoV-2 on human pancreatic islets. Diabetes. 2022;71:1579–1590. doi: 10.2337/db21-0926. - DOI - PMC - PubMed

Supplementary concepts